Hi 
The spin-off of Pfizer’s UpJohn business and its subsequent merger with Mylan has now been effective. The new company is called Viatris. We are due to receive the new shares today from our US partner and will be issued to our customer’s portfolio as soon as reasonably possible following receipt. We will notify our customers once these have been added.
